311 related articles for article (PubMed ID: 29848727)
1. Usefulness of Preoperative
Ikeno Y; Seo S; Yamamoto G; Nakamoto Y; Uemoto Y; Fuji H; Yoshino K; Yoh T; Taura K; Uemoto S
Anticancer Res; 2018 Jun; 38(6):3677-3682. PubMed ID: 29848727
[TBL] [Abstract][Full Text] [Related]
2. Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI.
Lee S; Kim MJ; Kim S; Choi D; Jang KT; Park YN
J Hepatol; 2019 Apr; 70(4):692-699. PubMed ID: 30553839
[TBL] [Abstract][Full Text] [Related]
3. Intraductal Papillary Neoplasm of the Bile Duct: Clinical, Imaging, and Pathologic Features.
Park HJ; Kim SY; Kim HJ; Lee SS; Hong GS; Byun JH; Hong SM; Lee MG
AJR Am J Roentgenol; 2018 Jul; 211(1):67-75. PubMed ID: 29629808
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".
Nakanuma Y; Sato Y; Ojima H; Kanai Y; Aishima S; Yamamoto M; Ariizumi S; Furukawa T; Hayashi H; Unno M; Ohta T;
Int J Clin Exp Pathol; 2014; 7(6):3112-22. PubMed ID: 25031730
[TBL] [Abstract][Full Text] [Related]
5. Morphological classification of intraductal papillary neoplasm of the bile duct.
Ying S; Ying M; Liang W; Wang Z; Wang Q; Chen F; Xiao W
Eur Radiol; 2018 Apr; 28(4):1568-1578. PubMed ID: 29138880
[TBL] [Abstract][Full Text] [Related]
6. Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET.
Sangfelt P; Sundin A; Wanders A; Rasmussen I; Karlson BM; Bergquist A; Rorsman F
J Hepatol; 2014 Dec; 61(6):1352-7. PubMed ID: 25111173
[TBL] [Abstract][Full Text] [Related]
7. Preoperative 18F-FDG PET-CT maximum standardized uptake value predicts recurrence of biliary tract cancer.
Park MS; Lee SM
Anticancer Res; 2014 May; 34(5):2551-4. PubMed ID: 24778075
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.
Moon CM; Bang S; Chung JB; Park SW; Song SY; Yun M; Lee JD
J Gastroenterol Hepatol; 2008 May; 23(5):759-65. PubMed ID: 17931372
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Aspects and Diagnostic Problems in Patients with Intraductal Papillary Neoplasm of the Bile Duct.
Nanashima A; Imamura N; Sumida Y; Hiyoshi M; Hamada T; Nagayasu T
Anticancer Res; 2018 Apr; 38(4):2343-2352. PubMed ID: 29599359
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of CT and MRI in distinguishing intraductal papillary neoplasm of the bile duct from cholangiocarcinoma with intraductal papillary growth.
Liu Y; Zhong X; Yan L; Zheng J; Liu Z; Liang C
Eur Radiol; 2015 Jul; 25(7):1967-74. PubMed ID: 25716939
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Occupational Cholangiocarcinoma.
Kinoshita M; Takemura S; Tanaka S; Shinkawa H; Hamano G; Ito T; Koda M; Aota T; Nakanuma Y; Sato Y; Nakamori S; Arimoto A; Yamamoto T; Toyokawa H; Kubo S
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1753-1759. PubMed ID: 30049183
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
Jung G; Park KM; Lee SS; Yu E; Hong SM; Kim J
J Hepatol; 2012 Oct; 57(4):787-93. PubMed ID: 22634127
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound Findings of Intraductal Papillary Neoplasm in Bile Duct and the Added Value of Contrast-Enhanced Ultrasound.
Liu LN; Xu HX; Zheng SG; Sun LP; Guo LH; Zhang YF; Xu JM; Liu C; Xu XH
Ultraschall Med; 2015 Dec; 36(6):594-602. PubMed ID: 25188491
[TBL] [Abstract][Full Text] [Related]
14. Preoperative staging of cholangiocarcinoma and biliary carcinoma using 18F-fluorodeoxyglucose positron emission tomography: a meta-analysis.
Hu JH; Tang JH; Lin CH; Chu YY; Liu NJ
J Investig Med; 2018 Jan; 66(1):52-61. PubMed ID: 28912249
[TBL] [Abstract][Full Text] [Related]
15. Impact of Tumor Location on Postoperative Outcome of Intraductal Papillary Neoplasm of the Bile Duct.
Matsumoto T; Kubota K; Hachiya H; Sakuraoka Y; Shiraki T; Shimizu T; Mori S; Iso Y; Kato M; Yamagishi H; Imai Y; Aoki T
World J Surg; 2019 May; 43(5):1313-1322. PubMed ID: 30659344
[TBL] [Abstract][Full Text] [Related]
16. Intraductal papillary neoplasm of the bile duct: review of updated clinicopathological and imaging characteristics.
Kim JR; Jang KT; Jang JY
Br J Surg; 2023 Aug; 110(9):1229-1240. PubMed ID: 37463281
[TBL] [Abstract][Full Text] [Related]
17. Intraductal papillary neoplasm of the bile duct (IPNB): CT and MRI appearance with radiology-pathology correlation.
Aslam A; Wasnik AP; Shi J; Sahai V; Mendiratta-Lala M
Clin Imaging; 2020 Oct; 66():10-17. PubMed ID: 32438236
[TBL] [Abstract][Full Text] [Related]
18. Premalignant lesions of cholangiocarcinoma: characteristics on ultrasonography and MRI.
Siripongsakun S; Sapthanakorn W; Mekraksakit P; Vichitpunt S; Chonyuen S; Seetasarn J; Bhumiwat S; Sricharunrat T; Srittanapong S
Abdom Radiol (NY); 2019 Jun; 44(6):2133-2146. PubMed ID: 30820627
[TBL] [Abstract][Full Text] [Related]
19. CT findings of intraductal papillary neoplasm of the bile duct: assessment with multiphase contrast-enhanced examination using multi-detector CT.
Ogawa H; Itoh S; Nagasaka T; Suzuki K; Ota T; Naganawa S
Clin Radiol; 2012 Mar; 67(3):224-31. PubMed ID: 21944774
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.
Goeppert B; Stichel D; Toth R; Fritzsche S; Loeffler MA; Schlitter AM; Neumann O; Assenov Y; Vogel MN; Mehrabi A; Hoffmann K; Köhler B; Springfeld C; Weichenhan D; Plass C; Esposito I; Schirmacher P; von Deimling A; Roessler S
Gut; 2022 Feb; 71(2):391-401. PubMed ID: 33468537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
